Expensive Cytotoxic Chemotherapy in the Management of Advanced Cancers in the Developing World

Publisher： Karger

E-ISSN： 1423-0232|78|1|3-4

ISSN： 0030-2414

Source： Oncology, Vol.78, Iss.1, 2010-03, pp. : 3-4

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Preoperative Chemotherapy and Metronomic Scheduling of Chemotherapy in Locally Advanced Oral Cancers

By  

Oncology, Vol. 91, Iss. 1, 2016-07 ,pp. : 35-40

Karger

Access to resources Recommend Favorite

Hepatitis B reactivation in patients receiving cytotoxic chemotherapy: Diagnosis and management

By  

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol. 25, Iss. 5, 2010-05 ,pp. : 864-871

John Wiley & Sons Inc

Access to resources Recommend Favorite

The management of cytotoxic chemotherapy extravasation: a systematic review of the literature to evaluate the evidence underpinning contemporary practice

By  

EUROPEAN JOURNAL OF CANCER CARE (ELECTRONIC), Vol. 24, Iss. 6, 2015-11 ,pp. : 771-800

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cytotoxic chemotherapy in the contemporary management of metastatic castration‐resistant prostate cancer (mCRPC)

By  

BJU INTERNATIONAL, Vol. 116, Iss. 1, 2015-07 ,pp. : 17-29

John Wiley & Sons Inc

Access to resources Recommend Favorite

Single-Nucleotide Polymorphisms in the Vascular Endothelial Growth Factor Pathway and Outcomes of Patients Treated with First-Line Cytotoxic Chemotherapy Combined with Bevacizumab for Advanced Colorectal Cancer

By  

Oncology, Vol. 87, Iss. 5, 2014-08 ,pp. : 280-292

Karger

Access to resources Recommend Favorite